Inflation, a key indicator closely watched by the Fed, is still at historically high levels. Is it going to slow down growth going forward? Drugmaker Merck’s stock is up 8 percent Friday. It says its experimental drug for COVID-19 cuts the risk of death or hospitalization by 50 percent. It’s applying for emergency use with…
Biden: Booster Shots Should Be Available ‘Basically Across the Board’ in the Future
While COVID-19 vaccine booster shots are now available to tens of millions of Americans, President Joe Biden signaled Friday that the boosters will in the future be authorized for practically anybody. The Food and Drug Administration this week expanded emergency use authorization for Pfizer’s COVID-19 vaccine, enabling certain groups to get a third dose of…
Pfizer COVID-19 Booster Shouldn’t Be Used for J&J, Moderna Vaccine Recipients: FDA Official
Pfizer’s COVID-19 booster shot should not be administered to those who previously received vaccines made by Moderna or Johnson & Johnson, said a top federal health official. Doran Fink, a deputy director in the Food and Drug Administration’s (FDA) vaccine regulation division, made the assessment during a Centers for Disease Control and Prevention (CDC) vaccine…
FDA Authorizes COVID-19 Boosters of Pfizer for Seniors and Those at High Risk
The Food and Drug Administration on Wednesday authorized for emergency use a booster dose of the Pfizer-BioNTech vaccine for those aged 65 and older, as well as those aged 18–64 who are at high risk of severe COVID-19. The third dose of the mRNA-based shot is authorized to be administered at least six months after the…
Facts Matter (Sept. 20): Why the FDA Panel Voted Against Recommending Pfizer Booster Shots to General Public
On Friday, the FDA’s vaccine advisory panel met, debated, and ultimately voted against approving vaccine booster shots for the general public. However, according to statements from the White House, as well as other government officials, it sounds like they might not listen to this advisory panel, and roll out booster shots anyway. Meanwhile, Pfizer announced…
NIH Director Collins Believes Pfizer Booster Shots Will Be Expanded Despite FDA Panel’s Recommendation
The head of the U.S. National Institutes of Health, Francis Collins, said he believes COVID-19 vaccine booster doses will be expanded despite a panel of Food and Drug Administration (FDA) experts recommending against them for the general population. With an overwhelming majority, the panel voted against recommending Pfizer’s COVID-19 booster for most of the general…
White House, HHS Defend Announcing Booster Shot Plan Ahead of Approval
The White House and federal health officials are standing by the decision to announce the plans for COVID-19 booster shots for many Americans back in August ahead of the Food and Drug Administration’s (FDA) and Center for Disease Control and Prevention’s (CDC) approval for the extra doses. The announcement issued by eight top government doctors…
FDA Panel Votes 16-3 Against Approving Pfizer COVID-19 Booster Shots
The U.S. Food and Drug Administration (FDA) advisory panel on Friday voted 16-3 to recommended against providing booster shots of the Pfizer COVID-19 vaccine for individuals aged 16 and older. Throughout the meeting, independent scientists to the FDA struck a skeptical tone on the need for boosters, or third doses, for Pfizer’s mRNA COVID-19 vaccine…
FDA Panel Votes Against Approving Pfizer COVID-19 Booster Shots for Everyone
The U.S. Food and Drug Administration’s vaccine advisory panel on Friday voted 16-3 to recommend against providing booster shots of the Pfizer COVID-19 vaccine for individuals aged 16 and older. The panel later voted to endorse the Pfizer booster for individuals who are aged 65 and older and for those who are at high risk….
FDA Panel Votes Against Pfizer’s COVID Booster for Everyone, Recommends It for People 65 and Older
The U.S. Food and Drug Administration’s vaccine advisory panel on Friday voted 16-3 to recommend against providing booster shots of the Pfizer COVID-19 vaccine for individuals aged 16 and older. The panel later voted to endorse the Pfizer booster for individuals who are aged 65 and older and for those who are at high risk….
US News
RSS Error: A feed could not be found at `https://www.theepochtimes.com/c-us/feed`; the status code is `200` and content-type is `text/html; charset=utf-8`